ADVM Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 5.30%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $57,705.96

Adverum Biotechnologies Insider Trading History Chart

Adverum Biotechnologies Share Price & Price History

^$1.68

▲ +0.13 (8.39%)

As of 09/22/2023 01:00 AM ET

Days: 30 | 90 | 365

His system isolated NVIDIA - Here's His Next Buy.

From Chaikin Analytics | Ad

Most investors don't know the truth about A.I. 50-year Wall Street Insider Marc Chaikin reveals what you should be doing to profit. Learn more here.

Learn more here.

Adverum Biotechnologies Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/15/2023	Setareh Seyedkazemi	Insider	Sell	6,201	$1.52	$9,425.52	47,674
3/15/2023	Brigit Riley	Insider	Sell	7,299	$0.78	$5,693.22	117,435
3/15/2023	Laurent Fischer	CEO	Sell	41,239	$0.78	$32,166.42	692,141
3/15/2023	Kishor Peter Soparkar	COO	Sell	13,360	$0.78	$10,420.80	265,891
9/19/2022	Laurent Fischer	CEO	Sell	41,082	$1.07	$43,957.74	727,380
9/19/2022	Richard Beckman	Insider	Sell	4,272	$1.07	$4,571.04	39,061
5/23/2022	Setareh Seyedkazemi	Insider	Buy	20,000	$0.84	$16,800.00	20,600
5/17/2022	Rupert D'souza	CFO	Buy	10,000	$0.83	$8,300.00	20,850
5/16/2022	Dawn Svoronos	Director	Buy	30,000	$0.85	$25,500.00	50,000
5/13/2022	Rupert D'souza	CFO	Buy	10,000	$0.86	$8,600.00	10,850
4/20/2022	Laurent Fischer	CEO	Buy	25,000	$1.11	$27,750.00	762,462
4/19/2022	Kishor Peter Soparkar	Insider	Buy	21,925	$1.14	$24,994.50	280,556
12/8/2021	Laurent Fischer	CEO	Buy	10,677	$1.79	$19,111.83
12/8/2021	Kishor Peter Soparkar	Insider	Buy	25,000	$1.91	$47,750.00
11/15/2021	James Paul Scopa	Director	Sell	50,000	$2.18	$109,000.00
9/30/2021	Julie Clark	Insider	Sell	4,766	$2.17	$10,342.22
3/24/2021	Laurent Fischer	CEO	Buy	10,000	$9.88	$98,800.00	26,292
2/9/2021	Leone D Patterson	CFO	Sell	12,533	$14.10	$176,715.30	98,017
1/15/2021	Laurent Fischer	CEO	Buy	8,600	$11.53	$99,158.00	16,292
1/15/2021	Patrick Machado	Director	Buy	10,000	$11.52	$115,200.00	78,182

Successful Options Trading Begins With…

From Tradewins | Ad

Options trading expert Wendy Kirkland’s free guide reveals the options trading principles that are as easy to implement as they are to learn and how using them could earn you thousands in extra income each month!

Download the guide here and see the difference!

SEC Filings (Institutional Ownership Changes) for Adverum Biotechnologies (NASDAQ:ADVM)

70.87% of Adverum Biotechnologies stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Adverum Biotechnologies Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/21/2023	Osaic Holdings Inc.	63,150	$100K	0.0%	-32.2%	0.063%
8/15/2023	Worth Venture Partners LLC	370,683	$0.59M	0.3%	+24.2%	0.367%
8/15/2023	XTX Topco Ltd	16,332	$26K	0.0%	N/A	0.016%
8/15/2023	Cantor Fitzgerald L. P.	162,838	$0.26M	0.0%	+14.0%	0.161%
8/15/2023	Commodore Capital LP	10,000,000	$15.90M	1.8%	+100.0%	9.902%
8/11/2023	VR Adviser LLC	3,886,246	$6.18M	1.0%	N/A	3.864%
8/11/2023	Renaissance Technologies LLC	1,216,641	$1.93M	0.0%	+7.0%	1.210%
8/11/2023	BlackRock Inc.	1,403,611	$2.23M	0.0%	-31.1%	1.396%
8/11/2023	Geode Capital Management LLC	887,046	$1.41M	0.0%	+12.6%	0.882%
8/10/2023	Osaic Holdings Inc.	63,150	$100K	0.0%	-32.2%	0.063%
8/10/2023	Charles Schwab Investment Management Inc.	36,413	$58K	0.0%	-42.1%	0.036%
8/8/2023	Monaco Asset Management SAM	235,000	$0.37M	0.1%	-64.4%	0.234%
8/3/2023	Bank of New York Mellon Corp	69,162	$0.11M	0.0%	+26.9%	0.069%
7/24/2023	BML Capital Management LLC	5,157,179	$8.20M	7.4%	-27.0%	5.128%
5/16/2023	Jane Street Group LLC	92,643	$66K	0.0%	+34.0%	0.092%
5/16/2023	Geode Capital Management LLC	787,900	$0.57M	0.0%	+2.0%	0.783%
5/15/2023	Commodore Capital LP	5,000,000	$3.59M	0.5%	N/A	4.971%
5/15/2023	Sonic GP LLC	2,000,000	$1.44M	1.1%	-56.1%	1.989%
5/15/2023	Two Sigma Advisers LP	675,985	$0.49M	0.0%	-7.5%	0.672%
5/15/2023	Two Sigma Investments LP	621,122	$0.45M	0.0%	-12.2%	0.618%
5/12/2023	Renaissance Technologies LLC	1,136,741	$0.82M	0.0%	+5.8%	1.130%
5/12/2023	BlackRock Inc.	2,037,550	$1.46M	0.0%	-14.9%	2.026%
5/12/2023	Dimensional Fund Advisors LP	184,146	$0.13M	0.0%	-8.4%	0.183%
5/10/2023	Connor Clark & Lunn Investment Management Ltd.	149,856	$0.11M	0.0%	-25.3%	0.149%
5/8/2023	CM Management LLC	375,000	$0.27M	0.3%	+275.0%	0.373%
2/15/2023	Jane Street Group LLC	69,160	$40K	0.0%	+400.3%	0.069%
2/15/2023	Sonic GP LLC	4,552,068	$2.64M	2.0%	N/A	4.564%
2/15/2023	Millennium Management LLC	361,101	$0.21M	0.0%	-58.2%	0.362%
2/15/2023	Morgan Stanley	7,135,052	$4.14M	0.0%	-0.5%	7.154%
2/14/2023	Marshall Wace LLP	341,397	$0.20M	0.0%	-32.5%	0.342%
2/14/2023	Two Sigma Investments LP	707,647	$0.41M	0.0%	-32.5%	0.710%
2/13/2023	BML Capital Management LLC	7,067,179	$4.10M	3.9%	N/A	7.086%
2/13/2023	Renaissance Technologies LLC	1,074,241	$0.62M	0.0%	-4.0%	1.077%
2/13/2023	Geode Capital Management LLC	772,152	$0.45M	0.0%	+2.2%	0.774%
2/13/2023	GSA Capital Partners LLP	830,829	$0.48M	0.1%	+950.7%	0.833%
2/10/2023	Bank of America Corp DE	5,591,896	$3.24M	0.0%	+55,529.7%	5.607%
2/9/2023	CM Management LLC	100,000	$58K	0.1%	N/A	0.100%
2/9/2023	Dimensional Fund Advisors LP	200,974	$0.12M	0.0%	-27.2%	0.202%
2/3/2023	Monaco Asset Management SAM	659,575	$0.38M	0.1%	+193.1%	0.661%
1/31/2023	Monaco Asset Management SAM	659,575	$0.38M	0.1%	+193.1%	0.661%
1/12/2023	Assenagon Asset Management S.A.	840,651	$0.49M	0.0%	-10.7%	0.843%
1/12/2023	Marquette Asset Management LLC	121,393	$70K	0.0%	+25.3%	0.122%
11/15/2022	Jacobs Levy Equity Management Inc.	556,214	$0.53M	0.0%	-5.3%	0.558%
11/15/2022	Two Sigma Advisers LP	1,051,800	$1M	0.0%	-30.1%	1.055%
11/15/2022	Two Sigma Investments LP	1,048,063	$1M	0.0%	-10.0%	1.051%
11/15/2022	Vanguard Group Inc.	4,001,205	$3.80M	0.0%	-3.8%	4.012%
11/15/2022	Quinn Opportunity Partners LLC	418,298	$0.40M	0.0%	-16.8%	0.419%
11/15/2022	Marshall Wace LLP	505,737	$0.48M	0.0%	N/A	0.507%
11/15/2022	Bank of New York Mellon Corp	54,601	$52K	0.0%	-21.7%	0.055%
11/15/2022	BlackRock Inc.	3,198,725	$3.04M	0.0%	-3.8%	3.207%
11/15/2022	Caas Capital Management LP	134,338	$0.13M	0.0%	N/A	0.135%
11/14/2022	Worth Venture Partners LLC	298,560	$0.28M	0.2%	+20.0%	0.302%
11/14/2022	Tudor Investment Corp Et Al	62,651	$60K	0.0%	N/A	0.063%
11/14/2022	683 Capital Management LLC	100,000	$95K	0.0%	-51.7%	0.101%
11/14/2022	Renaissance Technologies LLC	1,118,441	$1.06M	0.0%	+2.3%	1.132%
11/14/2022	Ergoteles LLC	368,684	$0.35M	0.0%	-12.2%	0.373%
11/10/2022	Connor Clark & Lunn Investment Management Ltd.	203,725	$0.19M	0.0%	+73.4%	0.206%
11/10/2022	Dimensional Fund Advisors LP	276,109	$0.26M	0.0%	-14.6%	0.280%
10/31/2022	Monaco Asset Management SAM	225,000	$0.21M	0.1%	-49.7%	0.228%
10/6/2022	Marquette Asset Management LLC	96,910	$92K	0.0%	-27.0%	0.098%
8/18/2022	Goldman Sachs Group Inc.	214,174	$0.26M	0.0%	-19.0%	0.217%
8/15/2022	State Street Corp	281,854	$0.34M	0.0%	-84.0%	0.285%
8/15/2022	Millennium Management LLC	1,038,458	$1.25M	0.0%	N/A	1.051%
8/13/2022	Renaissance Technologies LLC	1,093,041	$1.31M	0.0%	+175.7%	1.107%
8/12/2022	Northern Trust Corp	162,923	$0.20M	0.0%	-78.5%	0.165%
8/12/2022	Rafferty Asset Management LLC	69,954	$84K	0.0%	+55.9%	0.071%
8/12/2022	BNP Paribas Arbitrage SA	40,967	$49K	0.0%	+426.8%	0.041%
8/11/2022	JPMorgan Chase & Co.	1,631,334	$1.96M	0.0%	-3.3%	1.652%
8/5/2022	Connor Clark & Lunn Investment Management Ltd.	117,512	$0.14M	0.0%	-61.2%	0.119%
8/1/2022	Monaco Asset Management SAM	447,004	$0.54M	0.2%	N/A	0.453%
7/27/2022	Assenagon Asset Management S.A.	941,751	$1.13M	0.0%	-5.1%	0.953%
7/15/2022	Marquette Asset Management LLC	132,769	$0.16M	0.0%	+101.9%	0.134%
6/7/2022	Bank of America Corp DE	30,889	$40K	0.0%	-91.2%	0.031%
6/2/2022	Mirae Asset Global Investments Co. Ltd.	387,623	$0.51M	0.0%	-9.2%	0.392%
5/17/2022	Mirabella Financial Services LLP	24,200	$32K	0.0%	N/A	0.025%
5/17/2022	RTW Investments LP	223,725	$0.29M	0.0%	-97.0%	0.227%
5/16/2022	Goldman Sachs Group Inc.	264,273	$0.35M	0.0%	-45.5%	0.268%
5/16/2022	State Street Corp	1,757,495	$2.30M	0.0%	-4.5%	1.780%
5/16/2022	Invesco Ltd.	286,314	$0.38M	0.0%	+996.9%	0.290%
5/13/2022	Renaissance Technologies LLC	396,441	$0.52M	0.0%	-38.1%	0.401%
5/13/2022	Northern Trust Corp	758,580	$0.99M	0.0%	-4.0%	0.768%
5/13/2022	Charles Schwab Investment Management Inc.	195,885	$0.26M	0.0%	-9.4%	0.198%
5/13/2022	Vanguard Group Inc.	3,536,364	$4.63M	0.0%	-16.7%	3.581%
5/13/2022	Dimensional Fund Advisors LP	593,619	$0.78M	0.0%	-13.6%	0.601%
5/12/2022	BlackRock Inc.	7,315,539	$9.58M	0.0%	-0.4%	7.408%
5/12/2022	Connor Clark & Lunn Investment Management Ltd.	302,717	$0.40M	0.0%	-10.6%	0.307%
5/11/2022	JPMorgan Chase & Co.	1,687,273	$2.21M	0.0%	-18.1%	1.709%
5/11/2022	GSA Capital Partners LLP	395,585	$0.52M	0.1%	-24.3%	0.401%
5/10/2022	Mirae Asset Global Investments Co. Ltd.	387,623	$0.51M	0.0%	-9.2%	0.393%
5/5/2022	Russell Investments Group Ltd.	76,637	$100K	0.0%	-50.0%	0.078%
4/26/2022	Marquette Asset Management LLC	65,754	$86K	0.0%	+21.8%	0.067%
4/25/2022	Assenagon Asset Management S.A.	992,729	$1.30M	0.0%	+125.8%	1.005%
2/15/2022	683 Capital Management LLC	100,000	$0.18M	0.0%	-50.0%	0.102%
2/14/2022	Quinn Opportunity Partners LLC	503,004	$0.89M	0.1%	+102.8%	0.512%
2/14/2022	GSA Capital Partners LLP	522,284	$0.92M	0.1%	N/A	0.532%
2/11/2022	K2 Principal Fund L.P.	420,944	$0.74M	0.0%	-74.5%	0.429%
2/10/2022	Rafferty Asset Management LLC	49,107	$86K	0.0%	+47.9%	0.050%
2/10/2022	Connor Clark & Lunn Investment Management Ltd.	338,740	$0.60M	0.0%	-8.1%	0.345%
2/9/2022	BNP Paribas Arbitrage SA	175,109	$0.31M	0.0%	+872.0%	0.178%
2/9/2022	Dimensional Fund Advisors LP	687,130	$1.21M	0.0%	-8.1%	0.700%

Data available starting January 2016

Adverum Biotechnologies, Inc., a clinical-stage company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ixoberogene soroparvovec (ADVM-022), a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration and diabetic macular edema. The company is developing ADVM-062 (AAV.7m8-L-opsin), a novel gene therapy product candidate for the treatment of blue cone monochromacy via a single IVT injection. Adverum Biotechnologies, Inc. has license and collaboration agreements with University of California; GenSight Biologics; Lexeo Therapeutics; and Virovek, Inc. The company was formerly known as Avalanche Biotechnologies, Inc. and changed its name to Adverum Biotechnologies, Inc. in May 2016. Adverum Biotechnologies, Inc. was incorporated in 2006 and is headquartered in Redwood City, California.

Today's Range

Now: $1.68

$1.53

$1.70

50 Day Range

MA: $1.81

$1.52

$2.33

52 Week Range

Now: $1.68

$0.53

$2.34

Volume

296,600 shs

Average Volume

196,878 shs

Market Capitalization

$169.66 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.82

Who are the company insiders with the largest holdings of Adverum Biotechnologies?: Adverum Biotechnologies' top insider shareholders include:
Laurent Fischer (CEO)
Peter Soparkar (Insider)
Peter Soparkar (COO)
Brigit Riley (Insider)
Dawn Svoronos (Director)
Setareh Seyedkazemi (Insider)
Richard Beckman (Insider)
Rupert D'souza (CFO)
James Paul Scopa (Director)
Julie Clark (Insider)
Learn More about top insider investors at Adverum Biotechnologies.
Who are the major institutional investors of Adverum Biotechnologies?: Adverum Biotechnologies' top institutional shareholders include:
Commodore Capital LP — 9.90%
BML Capital Management LLC — 5.13%
VR Adviser LLC — 3.86%
BlackRock Inc. — 1.40%
Renaissance Technologies LLC — 1.21%
Geode Capital Management LLC — 0.88%
Learn More about top institutional investors of Adverum Biotechnologies stock.
Which major investors are selling Adverum Biotechnologies stock?: Within the previous quarter, ADVM stock was sold by these institutional investors:
BML Capital Management LLC
BlackRock Inc.
Monaco Asset Management SAM
Osaic Holdings Inc.
Osaic Holdings Inc.
Charles Schwab Investment Management Inc.
During the last year, company insiders that have sold Adverum Biotechnologies company stock include:
Laurent Fischer (CEO)
Peter Soparkar (Insider)
Peter Soparkar (COO)
Brigit Riley (Insider)
Learn More investors selling Adverum Biotechnologies stock.
Which major investors are buying Adverum Biotechnologies stock?: In the last quarter, ADVM stock was bought by institutional investors including:
Commodore Capital LP
VR Adviser LLC
Geode Capital Management LLC
Renaissance Technologies LLC
Worth Venture Partners LLC
Cantor Fitzgerald L. P.
XTX Topco Ltd
Bank of New York Mellon Corp
In the previous year, these company insiders have bought Adverum Biotechnologies stock:
Laurent Fischer (CEO)
Peter Soparkar (Insider)
Peter Soparkar (COO)
Brigit Riley (Insider)
Dawn Svoronos (Director)
Learn More investors buying Adverum Biotechnologies stock.